Swiss pharmaceutical company Roche announced Friday it will open an innovation center in the Harvard University Enterprise ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy ...

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.